• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Spironolactone and triamterene in volume-dependent essential hypertension.

作者信息

DeCarvalho J G, Emery A C, Frohlich E D

出版信息

Clin Pharmacol Ther. 1980 Jan;27(1):53-6. doi: 10.1038/clpt.1980.8.

DOI:10.1038/clpt.1980.8
PMID:6985854
Abstract

The effects of 2 potassium-retaining diuretics on arterial pressure, intravascular volume, responses of the renin-angiotensin-aldosterone system, serum electrolytes, and renal function were compared by means of an 8-wk double-blind, crossover trial in 13 patients with "volume-dependent" essential hypertension. The fall in systolic, diastolic, and mean arterial pressures in the supine and erect positions (all p less than 0.005) induced by spironolactone was greater than that by triamterene. The pressure fall induced by spironolactone was also associated with a persistent contraction in plasma volume (p less than 0.05) and a secondary hyperaldosteronism that was not accompanied by hypokalemic alkalosis. The pressure fall induced by triamterene was not associated with reduced plasma volume, effect on plasma renin activity, or aldosterone excretion. Both drugs produced significant rises in blood urea nitrogen and creatinine levels that never exceeded normal limits.

摘要

相似文献

1
Spironolactone and triamterene in volume-dependent essential hypertension.
Clin Pharmacol Ther. 1980 Jan;27(1):53-6. doi: 10.1038/clpt.1980.8.
2
Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.低肾素性原发性高血压的治疗。螺内酯与氢氯噻嗪-氨苯蝶啶联合用药的比较。
JAMA. 1974 Feb 4;227(5):518-21.
3
Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.氨苯蝶啶对原发性高血压患者尿中免疫反应性前列腺素E排泄的影响。
Tohoku J Exp Med. 1979 Nov;129(3):249-56. doi: 10.1620/tjem.129.249.
4
Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.盐皮质激素受体依赖性和非依赖性保钾利尿剂对纤溶平衡的不同影响。
Hypertension. 2005 Aug;46(2):313-20. doi: 10.1161/01.HYP.0000174327.53863.86. Epub 2005 Jul 5.
5
Triamterene-induced changes in aldosterone and renin values in essential hypertension. Evidence of a role for aldosterone in preventing blood pressure reduction.氨苯蝶啶对原发性高血压患者醛固酮和肾素值的影响。醛固酮在阻止血压降低中作用的证据。
Arch Intern Med. 1976 Jun;136(6):645-8.
6
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.螺内酯、氨氯吡咪、氯沙坦与噻嗪类药物(SALT)对低肾素性高血压和醛固酮-肾素比值升高患者的双盲交叉试验。
Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.
7
Renin-aldosterone profiling in hypertension.高血压中的肾素-醛固酮分析
Ann Intern Med. 1977 Nov;87(5):596-312. doi: 10.7326/0003-4819-87-5-596.
8
Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.螺内酯对原发性醛固酮增多症患者体液量及肾上腺类固醇的影响。
Jpn Circ J. 1984 Nov;48(11):1184-96. doi: 10.1253/jcj.48.1184.
9
Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.血浆肾素活性受抑制的原发性高血压研究:限盐时的钠排泄模式及螺内酯对血压和血浆肾素活性的影响
Jpn Circ J. 1972 Dec;36(12):1301-11. doi: 10.1253/jcj.36.1301.
10
Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.高血压、醛固酮增多且血浆肾素水平低的患者手术与长期螺内酯治疗的比较
Br Med J. 1972 Jun 24;2(5816):729-34. doi: 10.1136/bmj.2.5816.729.

引用本文的文献

1
ACE Inhibition to Distinguish Low-Renin Hypertension From Primary Aldosteronism.通过血管紧张素转换酶抑制来鉴别低肾素性高血压与原发性醛固酮增多症。
Hypertension. 2025 Jun;82(6):1046-1055. doi: 10.1161/HYPERTENSIONAHA.125.24711. Epub 2025 Mar 31.